Benzinga | Dec 17, 2021 09:54AM EST

Catalyst Bio FDA AccessData.gov Listing Shows Orphan Drug Designation For Co.'s ' Treatment of Bleeding Episodes in Patients with Hemophilia A or B, Including those with Inhibitors'

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=820721